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Murine models of Salmonella enterica serovar Typhimurium infection are one of the
commonest tools to study host-pathogen interactions during bacterial infections.
Critically, the outcome of S. Typhimurium infection is impacted by the genetic background
of the mouse strain used, with macrophages from C57BL/6 and BALB/c mice lacking
the capacity to control intracellular bacterial replication. For this reason, the use of
congenic strains, which mix the genetic backgrounds of naturally protected mouse
strains with those of susceptible strains, has the capacity to significantly alter results and
interpretation of S. Typhimurium infection studies. Here, we describe how macrophage
knockout cell lines generated by CRISPR/Cas9 gene editing can help determine the
contribution of background contaminations in the phenotypes of primary macrophages
from congenic mice, on the outcome of S. Typhimurium infection studies. Our own
experience illustrates how the CRISPR/Cas9 technology can be used to complement
pre-existing knockout models, and shows that there is great merit in performing
concurrent studies with both genetic models, to exclude unanticipated side-effects on
host-pathogen interactions.
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INTRODUCTION
The interaction between a pathogen and the innate immune system, one of the first lines of
host defense, is a crucial component in how an infection will resolve. Salmonella enterica serovar
Typhimurium (S. Typhimurium) is a non-typhoidal Salmonella strain and is commonly used to
study the role of innate immune pathways during host-pathogen interactions (Keestra-Gounder
et al., 2015). S. Typhimurium infects the intestine, invades the bloodstream and disseminates
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to the mouse liver and spleen. Critically, the capacity of
inbred mice to clear an S. Typhimurium infection is directly
related to their genetic background (O’brien et al., 1980), with
C3H/HeJ, C57BL/6, and BALB/c mice being more susceptible
than CBA, 129 or A/J lines (Monack et al., 2004; Loomis et al.,
2014; Keestra-Gounder et al., 2015). Susceptibility to acute S.
Typhimurium infection partially depends on select genes at
the interface of the host-pathogen interaction. For example,
C57BL/6 and BALB/c mice bear a mutation in natural resistance-
associated macrophage protein 1 (Nramp1) (Vidal et al., 1993),
which is thought to control the concentration of cations required
for intracellular bacterial survival (Goswami et al., 2001; Loomis
et al., 2014). The effect of the C57BL/6 and BALB/c background
on S. Typhimurium infection is not restricted to the mutation
in Nramp1, however, as illustrated by the observation that
transgenic C57BL/6 mice expressing functional Nramp1 still
succumb to infection, which is not the case of 129 mice (Monack
et al., 2004; Loomis et al., 2014).
Investigations of immune pathways involved in the response
to S. Typhimurium infection often rely on genetically modified
mice, where gene-specific targeting constructs alter gene
expression. Originally, this was predominantly carried out using
embryonic stem cells (ESCs) from the 129 mouse strain,
implanted into blastocysts from C57BL/6 mice (Eisener-Dorman
et al., 2009), resulting in chimera mice. Extensive backcrossing
on the C57BL/6 background was then carried out to selectively
enrich for the knockout alleles, and to reduce the 129 genetic
material. At least 10 generations were considered necessary for
removing 129 genetic contaminations, resulting in a theoretical
99.9% C57BL/6 genetic composition (Eisener-Dorman et al.,
2009). Such mice are referred to as congenic mice, and are
still widely used, with more than 8,000 lines from 129 ESCs
recently cataloged (Vanden Berghe et al., 2015). Comparisons
of the 129 and C57BL/6 genomes identified 1395 indels and
single nucleotide polymorphisms in 1084 genes, leading to 188
gained/lost STOP codons (Vanden Berghe et al., 2015). Such
widespread variations between 129 and C57BL/6 genomes mean
that 99.5% of the 8,000 congenic lines analyzed were affected by
∼20 passenger mutations within 10 centiMorgans of the gene
targeted (Vanden Berghe et al., 2015). Consequently, although
backcrossed >10 times, congenic mice are almost always affected
by passenger mutations in flanking genes, originating from the
129 ESC-derived genetic material (Vanden Berghe et al., 2015).
In addition, unlinked genetic loci from the 129 ESCs can also be
randomly selected on the C57BL/6 background, in spite of the
backcrosses (Eisener-Dorman et al., 2009).
Given the difference between C57BL/6 and 129 lineages
in host- S. Typhimurium interactions, it is likely that certain
phenotypes regarding S. Typhimurium infections in C57BL/6
congenic mice are wrongly attributed to a specific gene, rather
than to genetic contamination from the 129 background. In this
work, we originally observed a strong protective effect against
S. Typhimurium infection in a Tlr7-deficient congenic line,
and its associated primary macrophages. While attempting to
uncover how Tlr7-deficiency conferred this protective effect, we
discovered that these mice harbored a wild-type Nramp1G169
gene, normally mutated to Nramp1D169 in C57BL/6 mice. Given
the strong effect of Nramp1G169D mutation on S. Typhimurium
bacterial replication in vivo and in vitro (Vidal et al., 1993;
Govoni et al., 1999; Loomis et al., 2014), we speculated that
the protective effects seen in Tlr7-deficient congenic mice
and cells could be Nramp1-dependent, and mask a putative
Tlr7 contribution. To gain further insight into the role of
Tlr7-deficiency on S. Typhimurium infection, we repeated our
studies in Nramp1G169D-mutant Tlr7-deficient macrophage cell
lines generated with the CRISPR/Cas9 technology. These in
vitro studies revealed that Tlr7-deficiency had no impact on
S. Typhimurium infection. We propose that the concurrent
use of CRISPR/Cas9 gene editing in macrophage cell lines
and primary cells from pre-existing congenic knockout models
should become standard practice in host-pathogen studies to
exclude confounding results due to background contamination.
MATERIALS AND METHODS
Mice and Ethics Statement
The use of animals and experimental procedures were approved
by the Monash Medical Centre Ethics Committee under
reference MMCA/2010/53 and MMCA/2014/57. Colonies of
C57BL/6J (ARC) and Tlr7−/− mice (Wei et al., 2010)
were maintained at the Reid Animal Facility, University of
South Australia under specific pathogen-free conditions. For
Salmonella Typhimurium infection, 8–12-week-old female mice
were used.
Salmonella enterica serovar Typhimurium
Culture
Salmonella enterica serovar Typhimurium SL1344 were grown
overnight in Luria Broth (LB) at 37◦C and subcultured for
an additional 3 h before being centrifuged, washed in PBS and
resuspended in Dulbecco’s modified Eagle’s medium (DMEM).
Bacterial suspensions were adjusted to 1 × 107 colony forming
unit (CFU)/ml after measurement of optical density at 600 nm.
Animal Infection and Tissue Processing
For oral infection, mice were infected by oral gavage with 100 µl
of a suspension of S. Typhimurium at 1 × 107 CFU/ml or with
100 µl LB, after sodium bicarbonate-neutralization of stomach
acid. For intraperitoneal (i.p.) inoculation, 100 µl of a solution
of S. Typhimurium at 1 × 104 CFU/ml or 100 µl of LB was
injected per mouse. Mice were culled by isoflurane overdose and
cervical dislocation. Serum was collected in serum gel tubes and
stored at −80◦C until use. Half of the spleen and liver were
homogenized in LB, and dilutions of homogenates were plated
on LB agar plates for viable bacterial counts. Homogenates were
spun down, and supernatants were complemented with an anti-
protease cocktail before being used for ELISA. Half of the spleen
and liver were fixed in 10% formalin and embedded in paraffin.
Sections were stained with H&E and inflammatory scores were
blindly assessed as follows. For the white pulp of the spleen: grade
0, normal; grade 1, reactive spleen; grade 2, coalescence; grade 3,
microgranulomata; grade 4, loss of structure. For the red pulp
of the spleen: grade 0, normal; grade 1, increase in neutrophil
number; grade 2, microabscesses; grade 3, microabscesses and
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 2 March 2018 | Volume 8 | Article 87
Ferrand et al. CRISPR and Congenic Contaminations
granulomata; grade 4, thrombosis and vasculitis. For the portal
tract of the liver: grade 0, no inflammation; grade 1, acute
or chronic inflammation confined to the portal tract; grade 2,
acute or chronic inflammation expanding portal tract; grade
3, abscesses; grade 4, thrombosis and vasculitis. For the liver
parenchyma, grade 0, no inflammation; grade 1, acute or chronic
inflammation confined to the parenchyma; grade 2, acute or
chronic inflammation expanding parenchyma; grade 3, abscesses;
grade 4, thrombosis and vasculitis. Cumulative scores are shown
(maximum of 8 per organ).
Cell Culture and Stimulation
Primary bone marrow derived macrophages (BMMs) were
prepared as previously described (Ferrand and Gantier, 2016).
Briefly, femurs were flushed with DMEM complemented with
1x antibiotic/antimycotic and 10% fetal bovine serum (FBS)
(referred as complete DMEM hereafter), and cells were plated in
complete DMEM supplemented with 20% L-929 cell-conditioned
medium in T75 flasks for 6 days at 37◦C (with one change
of medium on day 3). WT C57BL/6 macrophages BMMs were
immortalized using the J2 retrovirus encoding v-raf and v-myc,
as previously reported (Roberson and Walker, 1988). Briefly,
primary BMMs differentiated in 20% L-929 cell-conditioned
medium were infected with the retrovirus with Polybrene. 24 h
after infection, the cells were rinsed and kept in 20% L-929
medium for 7 days. L-929 cell-conditioned medium was then
withdrawn and the cells cultured in complete DMEM until stable
growth was attained. RAW264.7 cells and immortalized WT
C57BL/6 macrophages were also grown in complete DMEM.
Cells were regularly tested for mycoplasma contaminations.
TLR ligands were directly added to medium at the following
final concentrations: 100 ng/ml Pam3CSK4 (TLR 1/2 agonist,
InvivoGen), 10µg/ml polyI:C (TLR 3 agonist, InvivoGen),
10 ng/ml LPS (TLR 4 agonist, LPS from E. coli Serotype O111:B4,
Enzo Life Sciences), 1µM R848 (TLR7 agonist, InvivoGen),
0.5–1µM ODN1826 (TLR9 agonist, T∗C∗C∗ A∗T∗G∗ A∗C∗G∗
T∗T∗C∗ C∗T∗G∗ A∗C∗G∗ T∗T, synthesized by IDT and
resuspended in RNase-DNase free water) and 0.5µg/ml Sa19
(TLR13 agonist, rG∗rG∗rA∗ rC∗rG∗rG∗ rA∗rA∗rA∗ rG∗rA∗rC∗
rC∗rC∗rC∗ rG∗rU∗rG∗ rG, synthesized by IDT and resuspended
in RNase-DNase free TE buffer). “∗” denotes a phosphorothioate
modification. “r” denotes an RNA base.
Gentamicin Assay
On day 6 of differentiation, 1.5 × 105 BMMs were seeded per
well in a 24-well plates in complete DMEM with 20% L-929 cell-
conditioned medium and incubated overnight at 37◦C. Thirty
minutes before infection, cells were washed twice with pure
DMEM and incubated for 30min before addition of 75 µl of
a suspension of 1 × 107 CFU/ml S. Typhimurium (MOI of 5).
Infected cells were incubated for 45min and rinsed with complete
DMEM containing 100µg/ml gentamicin for 10min to remove
extracellular bacteria. Cells were then incubated in complete
DMEM containing 10µg/ml gentamicin for an extra 5 h before
lysis in 180 µl 0.2% Igepal CA-630 in PBS and plated on LB agar
to determine viable bacterial counts arising from the intracellular
contents. Supernatants were collected and stored at −80◦C until
cytokine levels were assessed by ELISA.
mRNA Isolation and RT-qPCR
Total RNA was purified from 1.5 × 105 cells using the ISOLATE
II RNA kit (Bioline) according to the manufacturer’s instructions.
cDNA was synthesized from isolated RNA using the High-
Capacity cDNA Archive kit (ThermoFisher Scientific) according
to themanufacturer’s instructions. RT-qPCRwas carried out with
the Power SYBR Green PCR (ThermoFisher Scientific) on the
HT7900 RT-PCR system (Life Technologies). Each polymerase
chain reaction (PCR) was carried out in technical duplicate. Each
amplicon was sequence-verified and used to generate a standard
curve for the quantification of gene expression (used in each
run). Melting curves were used in each run to confirm specificity
of amplification. The primers used were the following: Mouse





For microarray analyses, Cy3-labeled cRNA was prepared from
0.1 µg total RNA of BMMs infected 24 h with S. Typhimurium
(MOI of 5), using the One-Color Low input Quick Amp
labeling Kit (Agilent, v6.6 September 2012), followed by RNeasy
column purification (Qiagen). 600 ng of Cy3-labeled cRNA was
fragmented at 60◦C for 30min in 1x Agilent fragmentation
buffer and 2x Agilent blocking agent. On completion, 25 µl of
2x Agilent gene expression hybridization buffer was added and
43 µl of sample hybridized for 17 h at 67◦C in a rotating Agilent
hybridization oven with one Agilent SurePrint G3 Mouse Gene
Expression 8 × 60K (028005) microarray. After hybridization,
microarrays were sequentially washed 1min at room temperature
with GE wash buffer 1 (Agilent) and 1min with 37◦C GE wash
buffer 2 (Agilent). Slides were scanned on the Agilent C DNA
microarray scanner using one-color scan settings for 8 × 60 k
array slides. The scanned images were analyzed with Feature
Extraction Software 11.0.1.1 (Agilent). Feature-extracted files
are available in GEO (GSE103750), and were normalized and
analyzed as follows. The probes that were not “Detected” in
any of the 7 samples (from 3 wild-type and 4 Tlr7−/−) were
removed. Log2 transformation and quantile normalization of
the data were conducted. Array weights were computed using
the “arrayWeights” function in the limma package. Correlated
samples from 2 separate experiments were handled by random
effect model through the R function “duplicateCorrelation” and
were accommodated in the following linear model. We fitted the
normalized data to a linear model using “lmFit,” while taking
into account the array weights and batch sample correlation.
Using the global FDR adjusted P-value of 0.05, 50 probes were
up regulated in Tlr7−/− and 41 down regulated in Tlr7−/−
comparing to WT cells with a log2 fold change ≥1. Figure 2 is
restricted to the genes with an official gene symbol. The log2
transformed quantile normalized data of the 7 samples were
submitted to GEO (GSE103750). Normalized data for genes were
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processed with the Morpheus visualization tool (Broad Institute)
for the creation of expression heat maps.
CRISPR Gene Editing
Cas9 ribonucleoprotein (RNP) assembly was performed
following the manufacturer’s recommendations (IDT). Briefly,
Alt-R R© CRISPR-Cas9 crRNA and tracrRNA were annealed in
equimolar concentrations to a final duplex concentration
of 45µM. The crRNA guide sequences employed were
AUUGUGUACCUGUUCUACUGGUUUUAGAGCUAUGCU
(for the Tlr7−/− RAW264.7 clone #1 only) and
UAUGGGACAUUAUAACAUCGGUUUUAGAGCUAUGCU
(for all the other clones)—the Tlr7-specific protospacer element
is underlined. 120 pmol of the resulting crRNA:tracrRNA was
mixed with 100 pmol of recombinant Cas9 protein (Alt-R R©
Cas9 Nuclease 3NLS) and set to incubate at room temperature
for 15min. Electroporation transfection of 500,000 immortalized
macrophages or RAW264.7 cells was performed using a mix of
90 µl of BTXPRESS electroporation buffer (BTX) and 10 µl of
the Cas9 RNP complex in an AMAXA Nucleofactor II (program
D032, Lonza). After 2 days recovery at 37◦C, cloning by limiting
dilution was performed and Tlr7 deficiency was identified by
functional assay and gene sequencing. Control clones went
through the same selection process. Sanger sequencing was
used to confirm the genomic mutations, however one clone of
Tlr7−/− RAW264.7 cells (clone #1) failed to sequence (but was
confirmed to be Tlr7-deficient by mass spectrometry).
ELISA
IL-6 and TNF-α in culture supernatants or serum were
detected using their respective BD OptEIA Mouse ELISA kits
(BD Biosciences). Cxcl1 was detected in tissue homogenates
using Mouse CXCL1 DuoSet ELISA (R&D systems). All kits
were used in accordance with the manufacturer’s instructions.
Tetramethylbenzidine substrate (ThermoFisher Scientific) was
used for quantification of the cytokines on a Fluostar OPTIMA
(BMG Labtech) plate-reader.
Protein Digestion, LC-MS/MS and
Label-Free Quantitation
2.5× 106 BMMswere infected with S. Typhimurium as described
in the gentamicin assay section (MOI 5). At 6 h post-infection,
cells were washed in cold PBS before being harvested using
a cell scraper in cold PBS. Cells were spun down, and pellets
were snap-frozen in liquid nitrogen before being stored at
−80◦C prior to subsequent analysis. Cell pellets were lysed
and processed by filter-aided sample preparation (FASP), as
previously described (Wisniewski et al., 2009). Briefly, cells
were lysed in 4% SDS, 0.1M Tris-HCl (pH 7.6), sonicated
and then reduced with 5mM tris(2-carboxyethyl)phosphine
(TCEP) at 60◦C for 30min before being passed over a FASP
column (Expedeon). Samples were alkylated and subjected to
tryptic digestion on-column overnight at 37◦C according to the
manufacturer’s instructions. Prior to mass spectrometry, FASP
eluates were acidified and peptides were further purified and
enriched using OMIX C18Mini-Bed tips (Agilent Technologies).
Using a Dionex UltiMate 3000 RSLCnano system equipped
with a Dionex UltiMate 3000 RS autosampler, an Acclaim
PepMap RSLC analytical column (75µm × 50 cm, nanoViper,
C18, 2µm, 100Å; Thermo Scientific) and an Acclaim PepMap
100 trap column (100µm × 2 cm, nanoViper, C18, 5µm,
100Å; Thermo Scientific), tryptic peptides were separated
by increasing concentrations of 80% ACN/0.1% formic acid
at a flow of 250 nL/min for 95min and analyzed with a
QExactive Plus mass spectrometer (Thermo Scientific). Data
was searched against the Mus musculus reference proteome
(revision as of 2016-08), canonical and isoform sequences
(consisting of 59,550 entries) using Maxquant (v1.5.2.8) (Cox
and Mann, 2008; Cox et al., 2014) with the following settings:
enzyme digestion set to trypsin (max missed cleavages of
two); fixed carbamidomethyl cysteine modification; max variable
modifications of five; minimum peptide length of 8 amino
acids, maximum peptide length of 25 amino acids; known
contaminants added to the search database; decoy database
set to reverse; 1% false discovery rate (FDR) for peptide
and protein identification; instrument parameters (including
ppm tolerance settings) were the default settings for Orbitrap
acquisition; label free quantitation (LFQ) was set to on and
with a minimum ratio count of 2. For LFQ analysis, the
Perseus (v1.5.3) software package was used (Tyanova et al.,
2016). Raw LFQ values were Log2-transformed, reverse and
contaminant sequences removed and rows set to require a
minimum of three valid values across the six samples (three wild-
type and three Tlr7−/−) (Supplementary Table 1). Any further
missing values were replaced by imputation according to the
normal distribution of the samples, with default values of width
(0.3) and down shift (1.8) selected (Supplementary Table 2).
Data were also analyzed by z-score normalization across each
sample row (Supplementary Table 3). For a list of all identified
peptides and assigned protein groups and MS metadata, refer
to Supplementary Tables 4, 5. Raw MS data has been deposited
on the ProteomeXchange PRIDE (PRoteomics IDEntifications
database at the European Bioinformatics Institute) (Vizcaino
et al., 2016) archive and can be accessed using the following
accession number: PXD007239.
Statistical Analyses
Statistical analyses were carried out using Prism 6 (GraphPad
Software Inc.). Two-tailed unpaired t-test or non-parametric
Mann-WhitneyU-tests were used to compare pairs of conditions.
Symbols used: ns: not significant, ∗P ≤ 0.05, ∗∗P ≤ 0.01,
∗∗∗P ≤ 0.001, ∗∗∗∗P ≤ 0.0001.
RESULTS
Tlr7-Deficient Mice Are Protected Against
S. Typhimurium Infection in Vivo
In an observation that underlines the complexity of host-
pathogen interactions, recruitment of the innate immune
system does not always favor the host, and can also facilitate
S. Typhimurium infection. This is illustrated with the case
in interferon (IFN) receptor deficient (Ifnar1−/−) mice and
Nlrp12-deficient mice that are partially protected against S.
Typhimurium infection (Robinson et al., 2012; Zaki et al., 2014).
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In this study, we were interested in defining whether engagement
of mouse Tlr7, which operates upstream of IFN production upon
detection of endosomal RNA, could also play a role during S.
Typhimurium infection. To this end, we infected Tlr7-deficient
C57BL/6 mice with S. Typhimurium by oral gavage and initially
assessed the survival of the mice compared to wild-type (WT)
C57BL/6 mice. Importantly, the Tlr7−/− colony used here was
generated using the CJ7 129 ESC line (Lund et al., 2004), and
had been backcrossed 10 times on the C57BL/6 background.
Because Tlr-deficient lines are usually maintained homozygous,
we used WT C57BL/6 from a different colony housed in the
same room to ensure that both colonies were exposed to the
same environmental entities (this is important for host-pathogen
interactions).
All the WT mice were highly sensitive to infection and
reached humane endpoints by days 5–7, against only one
Tlr7−/− mouse by day 13, the day at which the experiment
was stopped and all the Tlr7−/− mice were culled (Figure 1A).
FIGURE 1 | Tlr7-deficient mice are protected from S. Typhimurium infection in vivo. (A–E). WT and Tlr7−/− mice were infected with 1 × 106 (oral route) CFU of S.
Typhimurium. (A) Survival of infected mice was monitored for 13 days (n = 7 mice per group). STM: S. Typhimurium infected. Log-rank (Mantel-Cox) test comparing
both genotypes is shown. (B) Bacterial count in liver and spleen was measured at time of death shown in (A) by CFU assay (n = 7 mice per group—a value for one
WT mouse (liver) was under the detection limit and is not shown here). Median and unpaired Mann-Whitney U-tests are shown. (C) Bacterial counts in the liver and the
spleen were measured at day 5 post-infection by CFU assay. LB: Luria Broth, i.e., non-infected. STM: S. Typhimurium infected. Data shown is averaged from two
independent experiments (LB n = 3 mice; infected, n = 10 mice). Median and unpaired Mann-Whitney U-tests are shown. (D) Cumulative histological scores of liver
and spleen from (C). Median and unpaired Mann-Whitney U-tests are shown. (E) Serum levels of IL6 and TNF-α at day 5 post-infection were measured by ELISA from
the mice used in (C). Median and unpaired Mann-Whitney U-tests are shown. (F,G) WT and Tlr7−/− mice were infected (intraperitoneal route) with 1 × 103 CFU of S.
Typhimurium. (F) Bacterial counts in the liver and the spleen were measured at day 3 post-infection by CFU assay (LB = 3 mice, STM infected = 5 mice—a value for
one WT mouse (liver) was under the detection limit and is not shown here). Median and unpaired Mann-Whitney U-tests are shown. (G) Spleen cumulative histological
score at day 3 post-infection from the mice used in (F). Median and unpaired Mann-Whitney U-tests are shown. (H) Flow cytometry analysis of live monocytes
(CD45+ CD11b+) from the peritoneal cavities at day 3 post-infection (oral route same as A–E). Data is averaged from two independent experiments (LB = 3 mice,
infected = 7 mice) (median and unpaired Mann-Whitney U-tests are shown). (C,F) Dotted lines indicate the limit of detection. (B,C,F) CFU counts are shown relative
to tissue weight. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001.
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Bacterial burdens in the liver and spleen were assessed at death,
revealing strong protection in both organs of Tlr7−/− mice, as
reflected by >2 logs and >4 logs higher numbers of bacteria in
the liver and spleen, respectively, of WT animals (Figure 1B).
A similar observation was made when the mice from both
genotypes were infected for a similar 5-day period (Figure 1C).
Reduced bacterial replication in Tlr7−/−mice was also associated
with significantly decreased liver and spleen inflammation
(Figure 1D), and strongly reduced serum pro-inflammatory IL-
6 and TNF-α responses (Figure 1E). To define whether the
protective effect of Tlr7-deficiency on S. Typhimurium infection
was a function of the route of infection, we next infected
the mice with S. Typhimurium via the intraperitoneal (i.p.)
route. In agreement with our previous data, Tlr7−/− mice
were protected against i.p. infection, with significantly reduced
bacterial load in the spleen and liver, and reduced inflammation
at day 3 (Figures 1F,G). Finally, analysis of peritoneal exudate
cells (PECs), and mesenteric lymph node (MLN) cells from
both WT and Tlr7−/− mice indicated that monocyte numbers
were reduced in infected Tlr7−/− mice (Figure 1H and not
shown).
Tlr7-Deficient Primary Macrophages Are
Protected Against S. Typhimurium
Infection in Vitro
Macrophages are an essential component of S. Typhimurium
infection, being a cell type in which the bacterium can survive
and replicate before disseminating to the spleen and liver
(Keestra-Gounder et al., 2015). In light of the role of the
monocytic compartment seen previously, we next assessed
the role of Tlr7 in S. Typhimurium survival after infection
of BMMs. In agreement with a protective role for Tlr7-
deficiency against S. Typhimurium infection, we found that
primary Tlr7-deficient BMMs were more efficient at inhibiting
intracellular bacterial survival than their WT counterparts in the
gentamicin assay (Figure 2A). This did not relate to decreased
phagocytosis with Tlr7-deficiency given that bacterial survival
was significantly greater in Tlr7-deficient BMMs after 1 h
infection. Counter intuitively, Tlr7-deficient BMMs produced
significantly more pro-inflammatory cytokines than WT cells,
as evidenced by Cxcl1 and TNF-α levels (Figure 2B). We
speculated that this heightened cytokine response in vitro
could be due to the better capacity of the BMMs to kill
the intracellular pathogen, alleviating some of its negative
activities on innate immune responses. We hypothesized that
macrophage polarization may have been impacted by the
presence of Tlr7 and measured Arginase 1 (Arg1), a marker of
macrophage phenotype, finding that expression was significantly
increased upon infection in Tlr7-deficient BMMs (Figure 2C).
To better understand the mechanisms at play in the protective
action of Tlr7-deficiency, we next performed a microarray
analysis of BMMs 24 h after infection with S. Typhimurium
(Figure 2D). While WT and Tlr7-deficient BMMs exhibited
different gene expression profiles, we were surprised to find
that there was no enrichment for any pathways relating
to immune function (“cysteine-type endopeptidase inhibitor
activity” was the only GO term enriched) (Gene Ontology,
2015).
FIGURE 2 | Tlr7-deficient BMMs clear S. Typhimurium more efficiently than WT BMMs. (A) Primary BMMs from WT and Tlr7-deficient mice were infected for indicated
time prior intracellular survival assessment (gentamicin assay). NT: non-treated; STM: S. Typhimurium infected. Data shown is averaged from three mice in biological
duplicate (± s.e.m and unpaired t-tests are shown), and is representative of 6 independent experiments. (B) Supernatants of cells from (A) were collected at 6 h and
analyzed by specific ELISA. Data shown is averaged from three mice in biological duplicate (median with range and unpaired Mann-Whitney U-tests are shown), and
is representative of 3 independent experiments. (C) RT-qPCR analyses of Arg1 mRNA relative to 18S rRNA from BMMs infected for 24 h. Data shown is averaged
from six mice in biological duplicate, from two independent experiments (median and unpaired Mann-Whitney U-tests are shown). (D) Microarray analysis of BMMs
infected for 24 h with S. Typhimurium (each row represents BMM originating from a different mouse). TLR7KO refers to Tlr7−/− cells. Only the significantly different
genes are shown. *P ≤ 0.05, **P ≤ 0.01, ****P ≤ 0.0001.
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Identification of a Passenger Mutation in
Nramp1 in Tlr7-Deficient Mice
To complement the microarray approach, we next resorted to
mass spectrometry to analyze WT and Tlr7-deficient primary
BMMs. Critically, when comparing the protein expression profile
of non-infected primary BMMs, we noted that several proteins,
in addition to Tlr7, were differentially expressed in WT and
Tlr7−/− BMMs (Figure 3A). While these basal differences could
have been the result of an absence of Tlr7 itself or its downstream
signaling (e.g., Stat3 or Fv4), we noticed that the gene encoding
Nramp1 (Slc11a1), was expressed at much higher levels in
Tlr7−/− BMMs than their WT counterparts. C57BL/6 mice
have an Nramp1G169D mutation that is thought to destabilize
the protein and prevent its normal expression (Vidal et al.,
1996). Sanger sequencing of the Nramp1 genomic region from
the Tlr7-deficient mice confirmed that these mice expressed
the wild-type Nramp1G169 allele of 129 origin, instead of the
mutant Nramp1D169 allele normally found in WT C57BL/6
mice (Figure 3B). This finding suggested that the protective
effect seen in vivo and in vitro in Tlr7-deficient mice and
primary macrophages against S. Typhimurium infection, was
presumably partially dependent on the Nramp1G169 allele—
with similar protective effects of this allele previously reported
in vivo and in vitro (Govoni et al., 1999; Loomis et al.,
2014).
Tlr7CRISPR−/− Macrophage Cell Lines Are
Not Protected Against S. Typhimurium
Infection
To delineate the putative role of Tlr7 in S. Typhimurium
infection, independent of Nramp1G169, we generated two sets
of WT and Tlr7-deficient clones, with the transient transfection
of synthetic guide RNAs together with recombinant Cas9 into
RAW264.7 macrophages (derived from a BALB/c mouse), or
into immortalized BMMs (derived from a C57BL/6 mouse)—
both cell models being based on the mutant Nramp1D169
allele. It is noteworthy that RAW264.7 cells are an established
model of S. Typhimurium infection, in which the protective
effect conferred by a rescue of the Nramp1G169 allele has
previously been demonstrated (Govoni et al., 1999). Selective
Tlr7 functional ablation was confirmed using the synthetic
ligand R848, and the function of other TLRs was unaltered
(Figures 4A,B). The Tlr7-deficient cells were also validated
by Sanger sequencing (Figure 4C) or mass spectrometry (not
shown). Analysis of S. Typhimurium intracellular survival after
phagocytosis by these cell lines did not show any significant
difference in the absence of Tlr7 expression (Figures 4D,E).
In line with this, the Tlr7CRISPR−/− cells failed to produce
more pro-inflammatory cytokines than the WT cells upon
S. Typhimurium infection (Figures 4D,E). These findings
collectively supported that Tlr7-deficiency alone did not have any
significant impact on S. Typhimurium infection in immortalized
macrophages, in vitro, suggesting further that our observations
in primary BMMs from Tlr7-deficient mice were independent
of Tlr7.
FIGURE 3 | Tlr7-deficient mice have an Nramp1G169 allele. (A) Proteomic
analysis of non-infected primary BMMs by LC-MS/MS (n = 3 mice). A small
subset of differentially expressed proteins is shown here (normalized values
used in this heatmap are provided in Supplementary Table 2). (B)
Representative Sanger sequencing traces of the genomic region of
Nramp1G169 from C57BL/6 WT and Tlr7-deficient mice. The localization of the
sequence shown on chromosome 1 is provided for the first and last base
shown (referenced to the GRCm38/mm10 genome).
DISCUSSION
Background genetic contamination in animal studies has been
known for about 20 years, but has been often ignored by
researchers (Vanden Berghe et al., 2015). In 2011, however,
the discovery of a key role for a Casp11 mutation of 129
origin in a phenotype previously attributed to its neighboring
gene Casp1, reignited interest in the importance of ESC-
derived genetic material in the phenotype of congenic mice
(Kayagaki et al., 2011). Following on from this work, a recent
study indicates that up to 80% of genetically modified mice
cataloged in the “Mouse Genome Informatics” database were
generated through the use of ESCs from the 129 strain, in
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FIGURE 4 | Tlr7CRISPR−/− cells are not protected against S. Typhimurium infection. C57BL/6 immortalized macrophages (A) or RAW264.7 cells (B) electroporated
with Tlr7-specific crRNA-tacrRNA and Cas9 (see Material and Methods section) were separated into WT and Tlr7-deficient clones (KO), after screening for their
response to R848. Selected clones were further stimulated with indicated Tlr ligands: Pam3CSK4 (PAM3C) 100 ng/ml, polyI:C (pIC) 10µg/ml, LPS 10 ng/ml, R848
1µM, ODN1826 0.5–1µM, Sa19 0.5µg/ml). NT: non-treated. Supernatants were collected at 6 h and analyzed by TNF-α ELISA. Data shown is averaged from
biological duplicate for each clone studied, and representative of a minimum of 3 independent experiments for LPS and R848 (± s.e.m shown). The arrows point to
the loss of Tlr7 response to R848 in the selected clones. (C) Sequence alignment of Tlr7-deficient clones obtained from Sanger sequencing of purified genomic DNA.
The Tlr7-specific protospacer element in the crRNA is shown. The clone KO-RAW#1 did not amplify by PCR, but was confirmed to be Tlr7-deficient by mass
spectrometry. Intracellular survival of S. Typhimurium in C57BL/6 immortalized macrophage clones (D) or RAW264.7 clones (E) was assessed by gentamicin assay [in
biological triplicate (D) or quadruplicate (E)], at 6 h post-infection. Supernatants were also collected at this time point and analyzed for TNF-α levels. The survival data
shown is representative of 3 independent experiments (D). NT: non-treated; STM: S. Typhimurium infected.
which nearly all target genes were potentially accompanied
by mutations in neighboring genes affecting their expression
or function (Vanden Berghe et al., 2015). In light of these
contaminations and the differences in host-pathogen interactions
between 129 and C57BL/6 mice, it is critical to control
for unintended background mutations when conducting host-
pathogen studies.
One simple way to minimize the impact of such background
contaminations is to rely on the use of littermate controls
from heterozygote breeders rather than WT controls (Holmdahl
and Malissen, 2012). In our study, we compared Tlr7-deficient
congenic mice to non-littermate WT control mice on a C57BL/6
background, which is common practice in the field of innate
immunity to facilitate the comparison of several knockout
lines and to reduce the cost of heterozygous breeding. While
originally attributing the strong protective phenotype of Tlr7-
deficiency against S. Typhimurium infection to Tlr7, mass
spectrometry analyses revealed that our Tlr7-deficient congenic
mice harbored a wild-type allele of Nramp1 (Nramp1G169),
which is normally mutated into Nramp1D169 in C57BL/6 mice
(Vidal et al., 1993, 1996). The similarity of protection observed
in our in vivo experiments with those reported by others in
Nramp1G169 congenic animals (Loomis et al., 2014), suggested
that at least some of the phenotypes observed in our Tlr7-
deficient congenic mice (i.e., decreased bacterial load in liver
and spleen, and intracellular survival in primary BMMs), were
in fact due to the presence of Nramp1G169 in these animals.
In agreement with this, there was no significant impact of
Tlr7-deletion by CRISPR/Cas9 in Nramp1D169 macrophage cell
lines on S. Typhimurium infection. Although these in vitro
observations do not rule a possible contribution of Tlr7-
deficiency to the protective phenotype seen in vivo, independent
of Nramp1G169 and other putative passenger mutations present
in our line, they suggest that the role of Tlr7 is likely
to be limited, given that the macrophage compartment is
essential in the control of infection (Keestra-Gounder et al.,
2015). Nonetheless, further in vivo infection studies in another
colony of C57BL/6 or BALB/c Tlr7-deficient mice will be
necessary to firmly rule out a role of Tlr7 on S. Typhimurium
infection.
Our own journey illustrates the necessity for studies relying
on congenic strains to use littermate controls to minimize
the contributions of background mutations in phenotype
interpretations. While littermate breeding would most likely
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have avoided the initial interpretation of a protective effect of
Tlr7-deficiency, it would not have prevented the carryover of
putative flanking mutations from the 129 strain. Ideally, isogenic
lines should be preferred to congenic lines, but in light of their
near ubiquity, it is clear that many researchers will keep on
using congenic lines for some time. Importantly, it was recently
suggested that Cre/loxP-based conditional gene deletion would
avoid most passenger mutations, and as such, may constitute
a better alternative, when available, to studies with congenic
mice (Vanden Berghe et al., 2015). Nevertheless, such approaches
have their own limits and have the potential to introduce “Cre
effects,” possibly instigating potent immune responses (Pepin
et al., 2016).
Before discovering the Nramp1G169 allele in our congenic
animals, our data was converging toward a key role for Tlr7
in the control of S. Typhimurium infection. While unfortunate,
our experience is unlikely to be unique. It is most probable
that other works relating to host-pathogen interactions have
wrongly attributed an effect to a knockout gene, when in
fact pertaining to a congenic contamination. To prevent this,
and beyond a systematic genomic sequencing analysis of each
strains studied, we propose here that phenotypic validation
of host-pathogen interactions from congenic lines can be
rapidly carried out using immortalized cell lines generated with
CRISPR/Cas9 gene editing. CRISPR/Cas9 allows for the rapid
generation of immortalized cell lines with gene knockout activity
through recruitment of the Cas9 enzyme to a target locus
by a specific guide RNA, and the ensuing non-homologous
end joining repair that can ablate protein translation (Jinek
et al., 2012, 2013; Cong et al., 2013). In our study, we relied
on a transient CRISPR/Cas9 activity, through the use of an
electroporated synthetic guide RNA complex and recombinant
Cas9 in mouse macrophage lines. Screening of Tlr7CRISPR−/−
clones was performed through functional inhibition of Tlr7
sensing of its chemical ligand, and indels were confirmed by
Sanger sequencing. This approach was relatively rapid (∼4
weeks), and inexpensive. Given the importance of macrophages
in S. Typhimurium infection, this approach is very pertinent to
this pathogen, and should therefore become standard practice
to complement data from primary cells from congenic mice, to
help clear potential background contaminations existing in the
primary cells.
Finally, it is clear that CRISPR/Cas9 gene editing has its
own caveats, as illustrated with a recent genome sequencing
analysis of CRISPR/Cas9-mice that revealed the off-target
mutation of >40 gene exons (Schaefer et al., 2017). With the
increasing popularity of CRISPR/Cas9-mice for the study of gene
function, one should probably also consider how to examine
and account for unintended targeting in the interpretation
of host-pathogen interactions. Given the ever expanding tool
box available to study gene function, we suggest that when
applicable in vitro models are available (as seen here with
immortalized macrophages and S. Typhimurium), another gene
targeting approach should be used to validate the phenotype
of primary cells derived from CRISPR/Cas9-mice, during host-
pathogen interactions. Whether it is with stable small hairpin
RNA expression, zinc-finger nucleases, TALENs or congenic
cell lines, the concurrent use of two independent genetic
models should really become standard practice in the field,
to alleviate the unanticipated effects of the genetic model
itself.
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